Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept
These heterogeneous responses are modulated by multiple factors, including tumor classification, study methodology, treatment duration, and patient-specific parameters (Table 1)
Microbiome, immune modulation, tissue perfusion and sexual function pathways Microbiome and immune modulation as indirect drivers of infection risk or irritation Semaglutide and other GLP-1 receptor agonists are increasingly associated with changes in the gut microbiome in human and animal studies, though findings vary by agent and model
Type 2 focus: Synjardy is used for type 2 diabetes, not type 1 diabetes or diabetic ketoacidosis
Over time, this may contribute to sarcopenia: age-related muscle loss associated with reduced physical function, increased risk of falls, and other adverse health outcomes